The sinuses are air-filled cavities located around the nose and eyes that allow for air flow and drainage. In chronic sinusitis, the sinus linings become swollen (inflamed), preventing natural drainage of the pathways, leading to chronic infections and nasal blockage.
Treatments for chronic sinusitis
Medications often prescribed for chronic sinusitis patients:
If patients’ symptoms continue even with medications, sinus surgery may be an option. During the surgery, the Ear, Nose and Throat (ENT) surgeon will enter the sinuses through the nostrils to open blocked sinus pathways. Opening the inflamed sinus pathways allows the sinuses to drain better and improves air flow.
While surgery provides benefit to many patients, inflammation and scarring can take place even in the first 30 days, decreasing the effectiveness of surgery and causing symptoms to return. Now, there is an advanced technology that is clinically proven to reduce post-surgical inflammation and scarring.
Read on to learn more about the PROPEL® Sinus Stent.
PROPEL is clinically proven to improve surgical outcomes for chronic sinusitis sufferers.
When placed in the sinus following surgery, PROPEL decreases scarring and inflammation, reducing the need for additional surgical procedures as well as oral steroids2 and their potential side effects.
The spring-like PROPEL Sinus Stent props open the ethmoid sinus to maintain the surgical opening, delivers an anti-inflammatory medication directly to the sinus lining, and then dissolves.
Talk with your ENT specialist to see if PROPEL is the right option for you.
Your post-operative care may include saline sinus irrigation (e.g Neilmed Sinus Rinse™, available at most pharmacies), oral antibiotics and pain medicine. Take all of your medication as directed for the best outcomes.
Specific to the PROPEL Sinus Stent
The PROPEL sinus implant is intended for use in patients > 18 years of age following ehtmoid sinus surgery to maintain the sinus opening. This product is not intended for people who are allergic to the drug (mometasone furoate) or to certain polymers. Safety and effectiveness of the implant in pregnant or nursing females has not been studied. Risks may include pain/pressure, movement of the implant (within or out of the sinus) and possible side effects of the drug. The most common side effects in clinical studies were infection, headache and nose bleed. For more information on the risks and benefits of PROPEL, please talk to your doctor. The FDA approved labelling can be found at www.PROPELOPENS.com. Rx only.
©2015 Intersect ENT, Inc. All rights reserved, PROPEL is a trademark and registered trademark of Intersect ENT, Inc. MYSINUSITIS.COM is a trademark of Intersect ENT, Inc.
Call us today to schedule your appointment for a diagnosis and treatment for your nasal and sinus issues.